🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests whether panitumumab and pembrolizumab in combinat...
Status
Withdrawn
Location
M D Anderson Cancer Center
Start Date
2022-03-11
Trial ID
NCT05177796
Treatments Being Tested
This is a clinical research study taking place in Germany. Patients with co...
Status
Recruiting
Location
Charité - Universitaetsmedizin Berlin
Start Date
2025-04-10
Trial ID
NCT06922383
Treatments Being Tested
This phase III trial compares hepatic arterial infusion (HAI) (pump chemoth...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-10-19
Trial ID
NCT05863195
The purpose of this study is to evaluate the safety and tolerability of ima...
Status
Completed
Location
Virginia Cancer Specialists, PC
Start Date
2009-06
Trial ID
NCT00867334
Treatments Being Tested
The purpose of this study is to characterize the microscopic findings of sk...
Status
Completed
Location
Northwestern University
Start Date
2008-04
Trial ID
NCT00709878
Treatments Being Tested
This clinical trial evaluates the efficacy and safety of adding fecal micro...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04
Trial ID
NCT07509398
Treatments Being Tested
Background \& Rationale: Colon cancer is a leading cause of cancer deaths,...
Status
Recruiting
Location
Charité - Universitätsmedizin Berlin
Start Date
2024-10-22
Trial ID
NCT06490536
This phase II trial studies how well panitumumab, carboplatin and paclitaxe...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2016-11-03
Trial ID
NCT02593175
Treatments Being Tested
This phase III trial compares the effect of adding panitumumab to standard ...
Status
Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2026-05-13
Trial ID
NCT06998940
National trial, multicenter, randomized, phase II comparing treatment inten...
Status
Completed
Location
Ico Paul Papin
Start Date
2018-07-25
Trial ID
NCT03164655
Treatments Being Tested